Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  3/21/2018
University of Miami
mi
from
Miami, FL
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 3/21/2018
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Effects of Capros in Patients With Type-1 Diabetes
Effects of Capros Supplementation on Hyperglycemia in Patients With Type-1 Diabetes
Status: Enrolling
Updated:  3/21/2018
Carepoint East 543 Taylor Ave.
mi
from
Columbus, OH
Effects of Capros in Patients With Type-1 Diabetes
Effects of Capros Supplementation on Hyperglycemia in Patients With Type-1 Diabetes
Status: Enrolling
Updated: 3/21/2018
Carepoint East 543 Taylor Ave.
mi
from
Columbus, OH
Click here to add this to my saved trials
Effects of Capros in Patients With Type-1 Diabetes
Effects of Capros Supplementation on Hyperglycemia in Patients With Type-1 Diabetes
Status: Enrolling
Updated:  3/21/2018
Martha Morehouse Medical Plaza 2050 Kenny Road
mi
from
Columbus, OH
Effects of Capros in Patients With Type-1 Diabetes
Effects of Capros Supplementation on Hyperglycemia in Patients With Type-1 Diabetes
Status: Enrolling
Updated: 3/21/2018
Martha Morehouse Medical Plaza 2050 Kenny Road
mi
from
Columbus, OH
Click here to add this to my saved trials
Effects of Capros in Patients With Type-1 Diabetes
Effects of Capros Supplementation on Hyperglycemia in Patients With Type-1 Diabetes
Status: Enrolling
Updated:  3/21/2018
Davis Heart and Lung Research Institute
mi
from
Columbus, OH
Effects of Capros in Patients With Type-1 Diabetes
Effects of Capros Supplementation on Hyperglycemia in Patients With Type-1 Diabetes
Status: Enrolling
Updated: 3/21/2018
Davis Heart and Lung Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
PROTECT2: Diabetes Care - Eye Exam
PROTECT2: Diabetes Care - Eye Exam
Status: Enrolling
Updated:  3/21/2018
Dean McGee Eye Institute
mi
from
Oklahoma City, OK
PROTECT2: Diabetes Care - Eye Exam
PROTECT2: Diabetes Care - Eye Exam
Status: Enrolling
Updated: 3/21/2018
Dean McGee Eye Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Immune Tolerance Induction Study
An Exploratory Study of the Safety and Efficacy of Immune Tolerance Induction (ITI) in Patients With Pompe Disease Who Have Previously Received Myozyme
Status: Enrolling
Updated:  3/22/2018
Clinical Research Facility
mi
from
Louisville, KY
Immune Tolerance Induction Study
An Exploratory Study of the Safety and Efficacy of Immune Tolerance Induction (ITI) in Patients With Pompe Disease Who Have Previously Received Myozyme
Status: Enrolling
Updated: 3/22/2018
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Immune Tolerance Induction Study
An Exploratory Study of the Safety and Efficacy of Immune Tolerance Induction (ITI) in Patients With Pompe Disease Who Have Previously Received Myozyme
Status: Enrolling
Updated:  3/22/2018
Clinical Research Facility
mi
from
Durham, NC
Immune Tolerance Induction Study
An Exploratory Study of the Safety and Efficacy of Immune Tolerance Induction (ITI) in Patients With Pompe Disease Who Have Previously Received Myozyme
Status: Enrolling
Updated: 3/22/2018
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Immune Tolerance Induction Study
An Exploratory Study of the Safety and Efficacy of Immune Tolerance Induction (ITI) in Patients With Pompe Disease Who Have Previously Received Myozyme
Status: Enrolling
Updated:  3/22/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Immune Tolerance Induction Study
An Exploratory Study of the Safety and Efficacy of Immune Tolerance Induction (ITI) in Patients With Pompe Disease Who Have Previously Received Myozyme
Status: Enrolling
Updated: 3/22/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Immune Tolerance Induction Study
An Exploratory Study of the Safety and Efficacy of Immune Tolerance Induction (ITI) in Patients With Pompe Disease Who Have Previously Received Myozyme
Status: Enrolling
Updated:  3/22/2018
Clinical Research Facility
mi
from
Norfolk, VA
Immune Tolerance Induction Study
An Exploratory Study of the Safety and Efficacy of Immune Tolerance Induction (ITI) in Patients With Pompe Disease Who Have Previously Received Myozyme
Status: Enrolling
Updated: 3/22/2018
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Immune Tolerance Induction Study
An Exploratory Study of the Safety and Efficacy of Immune Tolerance Induction (ITI) in Patients With Pompe Disease Who Have Previously Received Myozyme
Status: Enrolling
Updated:  3/22/2018
mi
from
Haifa,
Immune Tolerance Induction Study
An Exploratory Study of the Safety and Efficacy of Immune Tolerance Induction (ITI) in Patients With Pompe Disease Who Have Previously Received Myozyme
Status: Enrolling
Updated: 3/22/2018
mi
from
Haifa,
Click here to add this to my saved trials
Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation
A Randomized, Placebo-Controlled Double-Blind Trial Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation: A Pilot Study
Status: Enrolling
Updated:  3/22/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation
A Randomized, Placebo-Controlled Double-Blind Trial Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation: A Pilot Study
Status: Enrolling
Updated: 3/22/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
GOLO Open-Label Pilot 1
An Open-Label Pilot Study Evaluating the Effect of the GOLO for Life Weight Management Program on Weight and Metabolic Syndrome Indicators in Patients With Type II Diabetes Mellitus
Status: Enrolling
Updated:  3/23/2018
Buynak Clinical Research, P.C.
mi
from
Valparaiso, IN
GOLO Open-Label Pilot 1
An Open-Label Pilot Study Evaluating the Effect of the GOLO for Life Weight Management Program on Weight and Metabolic Syndrome Indicators in Patients With Type II Diabetes Mellitus
Status: Enrolling
Updated: 3/23/2018
Buynak Clinical Research, P.C.
mi
from
Valparaiso, IN
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Topeka, KA
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Burbank, CA
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Burbank, CA
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Concord, CA
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Concord, CA
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Fresno, CA
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Lakewood, CA
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Lakewood, CA
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Mission Hills, CA
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Mission Hills, CA
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Palm Springs, CA
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Palm Springs, CA
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Roseville, CA
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Roseville, CA
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
San Luis Obispo, CA
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
San Luis Obispo, CA
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Meridian, ID
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Saint Louis, MO
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Henderson, NV
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Charlotte, NC
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Raleigh, NC
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Wilmington, NC
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Fargo, ND
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Damme,
A Study of LY2409021 in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Damme,
Click here to add this to my saved trials
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Status: Enrolling
Updated:  3/24/2018
David Grant Medical Center
mi
from
Fairfield, CA
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Status: Enrolling
Updated: 3/24/2018
David Grant Medical Center
mi
from
Fairfield, CA
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Cedar-Crosse Research Center
mi
from
Chicago, IL
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Cedar-Crosse Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Centex Studies, Inc.
mi
from
Lake Charles, LA
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Centex Studies, Inc.
mi
from
Lake Charles, LA
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research of West Florida, Inc.
mi
from
Tampa, FL
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research of West Florida, Inc.
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Cosmopolitan International Diabetes Center
mi
from
Columbia, MO
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Cosmopolitan International Diabetes Center
mi
from
Columbia, MO
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Cotton O'Neil Clinic
mi
from
Topeka, KA
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Cotton O'Neil Clinic
mi
from
Topeka, KA
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Dallas Diabetes and Endocrine Center
mi
from
Dallas, TX
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Dallas Diabetes and Endocrine Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
East West Medical Institute
mi
from
Honolulu, HI
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
East West Medical Institute
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Galenos Research
mi
from
Dallas, TX
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Galenos Research
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Iderc, P.L.C.
mi
from
Des Moines, IA
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Iderc, P.L.C.
mi
from
Des Moines, IA
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
John Muir Health Network - The Osteoporosis Center
mi
from
Concord, CA
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
John Muir Health Network - The Osteoporosis Center
mi
from
Concord, CA
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Mercy Medical Research Institute
mi
from
Springfield, MO
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Mercy Medical Research Institute
mi
from
Springfield, MO
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Midwest CRC
mi
from
Crystal Lake, IL
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Midwest CRC
mi
from
Crystal Lake, IL
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
National Research Institute
mi
from
Los Angeles, CA
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
National Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
New Horizon Research Center
mi
from
Miami, FL
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
New Horizon Research Center
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Oakwell Clinical Research
mi
from
San Antonio, TX
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Oakwell Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Palm Research Center
mi
from
Las Vegas, NV
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Palm Research Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
The Polyclinic
mi
from
Seattle, WA
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
The Polyclinic
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Rocky Mountain Diabetes and Osteoporosis Center
mi
from
Idaho Falls, ID
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Rocky Mountain Diabetes and Osteoporosis Center
mi
from
Idaho Falls, ID
Click here to add this to my saved trials